How Revance’s RT002 Is Poised to Shake Up the Aesthetics Industry
Wendy Lewis investigates the company’s plans for seeking FDA approval of the first potentially...
Read More
PRIME Journal is part of the Informa Markets Division of Informa PLC
PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
